AbbVie Inc. - 11 Feb 2025 SCHEDULE 13G Report for Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

Filing Manager: AbbVie Inc.
Reporting Manager: AbbVie Inc.
Security: Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: XLO
Shares outstanding: 48,309,178 shares
Disclosed Ownership: 4,347,826 shares
Ownership: 9%
Form type: SCHEDULE 13G
Filing time: 18 Feb 2025, 16:15:26 UTC
Date of event: 11 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
AbbVie Inc.	9%	4,347,826	4,347,826	0	/s/ Scott T. Reents	Scott T. Reents, Executive Vice President, Chief Financial Officer